These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 19173816)
1. [Combination of docetaxel and capecitabine for the treatment of anthracycline-resistant advanced breast carcinoma]. Zhang JD; Shao ZY Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):787-9. PubMed ID: 19173816 [TBL] [Abstract][Full Text] [Related]
2. [Docetaxel and capecitabine combination chemotherapy for patients with anthracycline-resistant metastatic breast cancer]. Li SF; Wang X; Wang C; He LH; Shi YH; Hao CF; Dong GL; Tong ZS Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):944-6. PubMed ID: 19174000 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of docetaxel combined capecitabine on metastatic breast cancer]. Wang XX; Zhou ZM; Yuan ZY; Zhang DS; Shi YX; Jiang WQ Ai Zheng; 2007 Apr; 26(4):407-10. PubMed ID: 17430662 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of regimens of capecitabine-based chemotherapy in the treatment of advanced breast cancer]. Huang HY; Jiang ZF; Wang T; Zhang SH; Bian L; Cao Y; Wu SK; Song ST Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):850-3. PubMed ID: 22335952 [TBL] [Abstract][Full Text] [Related]
5. Final results of a phase II clinical trial of weekly docetaxel in combination with capecitabine in anthracycline-pretreated metastatic breast cancer. Mackey JR; Tonkin KS; Koski SL; Scarfe AG; Smylie MG; Joy AA; Au HJ; Bodnar DM; Soulieres D; Smith SW Clin Breast Cancer; 2004 Oct; 5(4):287-92. PubMed ID: 15507175 [TBL] [Abstract][Full Text] [Related]
6. Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes. Fan Y; Xu B; Yuan P; Wang J; Ma F; Li Q; Zhang P; Li Q; Cai R Chemotherapy; 2010; 56(4):340-7. PubMed ID: 20720418 [TBL] [Abstract][Full Text] [Related]
7. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644 [TBL] [Abstract][Full Text] [Related]
8. A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer. Bayo J; Lomas M; Salvador J; Moreno A; Ruiz M; Rodríguez A; Fuentes J; Fernández-Freire A; Bernabé R; Fernández A Clin Transl Oncol; 2008 Dec; 10(12):817-25. PubMed ID: 19068453 [TBL] [Abstract][Full Text] [Related]
9. A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. Karachaliou N; Ziras N; Syrigos K; Tryfonidis K; Papadimitraki E; Kontopodis E; Bozionelou V; Kalykaki A; Georgoulias V; Mavroudis D Cancer Chemother Pharmacol; 2012 Jul; 70(1):169-76. PubMed ID: 22669571 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine. Ito Y; Osaki Y; Tokudome N; Sugihara T; Takahashi S; Iwase T; Hatake K Breast Cancer; 2009; 16(2):126-31. PubMed ID: 18807123 [TBL] [Abstract][Full Text] [Related]
11. Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer. Wang HQ; Qian ZZ; Liu XM; Zhang HL; Li LF; Qiu LH; Hou Y; Zhou SY; Hao XS; Xie CH Chin Med J (Engl); 2010 Nov; 123(22):3212-6. PubMed ID: 21163117 [TBL] [Abstract][Full Text] [Related]
12. Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study. Rosati G; Bilancia D; Germano D; Dinota A; Romano R; Reggiardo G; Manzione L Ann Oncol; 2007 Jun; 18 Suppl 6():vi128-32. PubMed ID: 17591806 [TBL] [Abstract][Full Text] [Related]
13. [Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer]. Zhang J; Xiao Y; Lu M; Li J; Zhang XD; Li Y; Shen L Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):312-5. PubMed ID: 19615292 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial. Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826 [TBL] [Abstract][Full Text] [Related]
15. A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines. Campone M; Dobrovolskaya N; Tjulandin S; Chen SC; Fourie S; Mefti F; Konstantinova M; Lefresne F; Meheust N; Jassem J Breast J; 2013; 19(3):240-9. PubMed ID: 23528159 [TBL] [Abstract][Full Text] [Related]
16. Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer. Waters SH; Gillibrand A; Berry H; Kumar S; Velikova G; Dodwell DJ; Perren TJ Cancer Chemother Pharmacol; 2009 Jul; 64(2):407-12. PubMed ID: 19455333 [TBL] [Abstract][Full Text] [Related]
17. Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results. Michalaki V; Fotiou S; Gennatas S; Gennatas C Anticancer Res; 2010 Jul; 30(7):3051-4. PubMed ID: 20683054 [TBL] [Abstract][Full Text] [Related]
18. [Docetaxel combined with cisplatin in the treatment of anthracycline-resistant advanced breast cancer]. Xu BH; Zhao LM; Wang JY; Yuan P Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):471-3. PubMed ID: 17152499 [TBL] [Abstract][Full Text] [Related]
19. Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results. Michalaki V; Gennatas S; Gennatas K Anticancer Drugs; 2009 Mar; 20(3):204-7. PubMed ID: 19174694 [TBL] [Abstract][Full Text] [Related]
20. An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study. Wang Z; Lu J; Leaw S; Hong X; Wang J; Shao Z; Hu X Cancer Chemother Pharmacol; 2012 Feb; 69(2):515-22. PubMed ID: 21874317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]